[Progress in diagnosis of and therapy for cerebral infarction in patients with diabetes mellitus].
Kobayashi
Shotai
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D007333:Insulin Resistance; D018384:Oxidative Stress; D011379:Prognosis; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors